PARP inhibitors are a group of pharmacological inhibitors of the enzyme poly ADP ribose polymerase (PARP).
They are developed for multiple indications; the most important is the treatment of cancer. Several forms of cancer are more dependent on PARP than regular cells, making PARP an attractive target for cancer therapy. PARP inhibitors appear to improve progression-free survival in women with recurrent platinum-sensitive ovarian cancer, as evidenced mainly by olaparib added to conventional treatment.
In our report, we only study four approved PARPi (Lynparza, Zejula, Rubraca and Talzenna). One unit is one tablet or one capsule.
The global PARP (Poly ADP-Ribose Polymerase) Inhibitor market was valued at US$ 5139 million in 2023 and is anticipated to reach US$ 9258 million by 2030, witnessing a CAGR of 8.9% during the forecast period 2024-2030.
Global PARP (Poly ADP-Ribose Polymerase) Inhibitor key players include AstraZeneca, Tesaro, Merck & Co, etc. Global top three manufacturers hold a share about 90%.
North America is the largest market, with a share about 70%, followed by Europe and Emerging Country, both have a share about 25 percent.
In terms of product, Lynparza is the largest segment, with a share over 65%. And in terms of application, the largest application is Ovarian Cancer, followed by Breast Cancer.
This report aims to provide a comprehensive presentation of the global market for PARP (Poly ADP-Ribose Polymerase) Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PARP (Poly ADP-Ribose Polymerase) Inhibitor.
The PARP (Poly ADP-Ribose Polymerase) Inhibitor market size, estimations, and forecasts are provided in terms of sales quantity (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PARP (Poly ADP-Ribose Polymerase) Inhibitor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PARP (Poly ADP-Ribose Polymerase) Inhibitor manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of PARP (Poly ADP-Ribose Polymerase) Inhibitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Sales, revenue of PARP (Poly ADP-Ribose Polymerase) Inhibitor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
- ★ What Is The Overall Market Size And Projected Growth Rate Across Global And Regional Segments?
- ★ How Does The Market Size And Growth Outlook Vary Across Major Countries?
- ★ Which Region Or Market Sub-Segment Is Anticipated To Dominate Growth During The Forecast Period?
- ★ What Are The Primary Factors Expected To Drive Market Expansion, And What Challenges May Restrain Growth?
- ★ Which Emerging Technologies And Market Trends Are Shaping The Future Landscape?
- ★ What Are The Most Significant Opportunities Available In The Market?
- ★ Who Are The Leading Manufacturers Actively Participating In The Global Market?
- ★ Which Company Currently Holds The Largest Share Of The Market?
- ★ What Are The Potential Growth Avenues For New Entrants In The Global Market?